{"text": ["Why", "Did", "JNJ", "Scrap", "Its", "Alzheimer\u2019s", "Drug", "Mid-Stage", "Trial?"], "created_at": "2018-05-22 16:40:12"}
{"text": ["Amgen's", "Label", "Expansion", "Application", "for", "Prolia", "Gets", "FDA", "Nod"], "created_at": "2018-05-22 14:48:36"}
{"text": ["Amgen's", "Label", "Expansion", "Application", "for", "Prolia", "Gets", "FDA", "Nod"], "created_at": "2018-05-22 14:48:36"}
{"text": ["Eli", "Lilly\u2019s", "Elanco", "in", "Q1", "2018"], "created_at": "2018-05-22 14:30:15"}
{"text": ["Eli", "Lilly\u2019s", "Cardiovascular", "Products", "in", "Q1", "2018"], "created_at": "2018-05-22 13:01:13"}
{"text": ["Lilly's", "Taltz\u00ae", "(ixekizumab)", "Receives", "the", "First", "U.S.", "FDA", "Approval", "for", "Label", "Update", "to", "Include", "Data", "for", "Psoriasis", "Involving", "the", "Genital", "Area"], "created_at": "2018-05-22 12:30:00"}
{"text": ["Eli", "Lilly\u2019s", "Oncology", "Products", "in", "Q1", "2018"], "created_at": "2018-05-22 11:31:17"}
{"text": ["Eli", "Lilly", "And", "Co.", "To", "Present", "At", "UBS", "Global", "Conference;", "Webcast", "At", "10:30", "AM", "ET"], "created_at": "2018-05-22 09:33:00"}
{"text": ["Eli", "Lilly", "And", "Co.", "To", "Present", "At", "UBS", "Global", "Conference;", "Webcast", "At", "10:30", "AM", "ET"], "created_at": "2018-05-22 09:33:00"}
{"text": ["Eli", "Lilly:", "FDA", "Approves", "Label", "Update", "For", "Taltz", "-", "Quick", "Facts"], "created_at": "2018-05-22 08:39:00"}
{"text": ["Eli", "Lilly:", "FDA", "Approves", "Label", "Update", "For", "Taltz", "-", "Quick", "Facts"], "created_at": "2018-05-22 08:39:00"}
